Cytokinetics | CYTK - Debt

Stock Price
75.85
Daily Change
-2.79 -3.55%
Monthly
15.94%
Yearly
144.68%
Q2 Forecast
74.33

Cytokinetics reported $1.29B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Acadia Pharmaceuticals USD 52.19M 2.62M Dec/2025
Amgen USD 54.6B 17M Dec/2025
Arca Biopharma USD 0 0 Mar/2025
Bayer EUR 36.45B 2.93B Dec/2025
Biogen USD 6.56B 275.1M Mar/2026
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 1.29B 4.48M Mar/2026
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.5B 3.6M Dec/2025
Exelixis USD 169.54M 3.5M Mar/2026
Geron USD 121.99M 76K Dec/2025
Halozyme Therapeutics USD 2.14B 631.87M Dec/2025
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
Ligand Pharmaceuticals USD 451.49M 494K Dec/2025
Merck USD 49.34B 7.97B Dec/2025
Novartis USD 47B 11.62B Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Regeneron Pharmaceuticals USD 2.71B 300K Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 20.33B 1.43B Dec/2025